D21 Catégorie · précision supplémentaire requise Other benign neoplasms of connective and other soft tissue
ICD-10-CM D21 identifies “Other benign neoplasms of connective and other soft tissue” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Includes11
- benign neoplasm of blood vessel
- benign neoplasm of bursa
- benign neoplasm of cartilage
- benign neoplasm of fascia
- benign neoplasm of fat
- benign neoplasm of ligament, except uterine
- benign neoplasm of lymphatic channel
- benign neoplasm of muscle
- benign neoplasm of synovia
- benign neoplasm of tendon (sheath)
- benign stromal tumors
Excludes 113
- benign neoplasm of articular cartilage (D16.-)
- benign neoplasm of cartilage of larynx (D14.1)
- benign neoplasm of cartilage of nose (D14.0)
- benign neoplasm of connective tissue of breast (D24.-)
- benign neoplasm of peripheral nerves and autonomic nervous system (D36.1-)
- benign neoplasm of peritoneum (D20.1)
- benign neoplasm of retroperitoneum (D20.0)
- benign neoplasm of uterine ligament, any (D28.2)
- benign neoplasm of vascular tissue (D18.-)
- hemangioma (D18.0-)
- lipomatous neoplasm (D17.-)
- lymphangioma (D18.1)
- uterine leiomyoma (D25.-)
Instructions des niveaux supérieurs
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Codes plus précis
D21.0Benign neoplasm of connective and other soft tissue of head, face and neckCode facturable et spécifiqueD21.1Benign neoplasm of connective and other soft tissue of upper limb, including shoulderCatégorie · précision supplémentaire requiseD21.2Benign neoplasm of connective and other soft tissue of lower limb, including hipCatégorie · précision supplémentaire requiseD21.3Benign neoplasm of connective and other soft tissue of thoraxCode facturable et spécifiqueD21.4Benign neoplasm of connective and other soft tissue of abdomenCode facturable et spécifiqueD21.5Benign neoplasm of connective and other soft tissue of pelvisCode facturable et spécifiqueD21.6Benign neoplasm of connective and other soft tissue of trunk, unspecifiedCode facturable et spécifiqueD21.9Benign neoplasm of connective and other soft tissue, unspecifiedCode facturable et spécifiqueRéférences de l’index officiel
Références depuis d’autres codes (2)
Excludes 1 · benign neoplasm of synovia (D21.-)
Code first · neoplasm (C49.-, C79.89, D21.-, D48.1-)
Historique
Historique du code
Aucune modification depuis la première observation
ModifiéInchangé
FY2016
En vigueur dès le
- Première observation
Other benign neoplasms of connective and other soft tissue
Catégorie — choisir un code plus précis
CDC/NCHS · FY2016Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Aucun changement tabulaire |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.